AMD
Clinical trials for AMD explained in plain language.
Never miss a new study
Get alerted when new AMD trials appear
Sign up with your email to follow new studies for AMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a modified vitamin a pill save sight in dry AMD?
Disease control CompletedThis study tests a daily pill called ALK-001, a modified form of vitamin A, to see if it can slow the growth of geographic atrophy—an advanced form of dry age-related macular degeneration that causes blind spots. About 300 people with the condition took either the drug or a place…
Matched conditions: AMD
Phase: PHASE2, PHASE3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Study reveals how eye damage tracks with vision decline in dry AMD
Knowledge-focused CompletedThis study examined how vision loss progresses in people with geographic atrophy, an advanced form of dry age-related macular degeneration. Researchers analyzed past medical records and eye images from 60 patients to see which retinal changes are linked to faster vision decline. …
Matched conditions: AMD
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Eye fluid study sheds light on AMD treatment effects
Knowledge-focused CompletedThis study looked at 30 patients with a type of age-related macular degeneration (AMD) to see how treatment affects the barrier between blood and eye fluid. Researchers measured protein levels in the eye fluid before and during anti-angiogenic therapy. The goal was to better unde…
Matched conditions: AMD
Phase: NA • Sponsor: The Filatov Institute of Eye Diseases and Tissue Therapy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New eye scan could spot early signs of wet AMD returning
Knowledge-focused CompletedThis study tested a new, non-invasive eye scan called OCT angiography to see if it can better detect changes in abnormal blood vessels in people with wet age-related macular degeneration (AMD) who are being treated with Eylea. Researchers followed 49 patients to compare the new s…
Matched conditions: AMD
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:41 UTC